AARTI DRUGS LTD.

Aarti Drugs Limited through its subsidiaries engages in the pharmaceuticals business in India and internationally. The company offers active pharmaceutical ingredients in various therapeutic categories including anti-inflammatory cardioprotectants antidiarrhoeals antifungals antiarthritis/osteoporosis antibiotics antidiabetics Alzheimer's treatment sedatives vitamins and alcoholism treatment; and pharmaceutical intermediate products comprising tinidazole celecoxib ciprofloxacin clopidogrel diclofenac ketoconazole nimesulide and raloxifene. It also offers specialty chemical products such as benzene sulphonamide benzene sulphonic acid benzene sulphonic acid methyl ester benzene sulphonyl chloride cipro Q acid levofloxacin Q acid methyl nicotinate N-methyl methane sulphonamide diphenyl sulphone norofloxacin Q acid ofloxacin Q acid ortho para toluene sulphonamide ortho/para toluene sulphonic acid methyl ester para chloro benzene sulphonamide para chloro benzene sulphonyl chloride para toluene sulphonamide para toluene sulphonic acid methyl ester para toluene sulphonyl chloride and sodium benezene sulfinate as well as para toluene sulphonyl hydrazide and benzene sulphonic acid and sodium salt; and benzyl nicotinate bisphenol " C bisphenol "" C(chloride) ethyl nicotinate ethyl para toluene sulphonate and N-methyl imidazole. In addition the company's products under development comprise Acamprosate for alcoholism; Dabigatran for use as an anticoagulant; Sevelamer for antihyperphosphatemia; Colsevelam for anti-cholestrol treatment; Drondarone and Olmesartan for the treatment of cardiovascular diseases; Valasartan for use as cardiprotectant; and Sitagliptin for use as an antidiabetic. Further it offers contract manufacturing services. The company was incorporated in 1984 and is headquartered in Mumbai India."